Search results for "bile acid"

showing 10 items of 118 documents

Combined pharmacological treatment of heterozygous familial hypercholesterolemia

1990

Combined therapy of heterozygous familial hypercholesterolemia using a non-systemically acting drug (bile acid sequestrants) and a systemically acting one is frequently employed in clinical practice. A brief review of this topic is presented, with particular emphasis on the use of cholestyramine combined with pravastatin, a new HMG CoA reductase inhibitor.

DrugCholestyramineBile acidbiologymedicine.drug_classbusiness.industrymedia_common.quotation_subjectnutritional and metabolic diseasesFamilial hypercholesterolemiaMevalonic acidPharmacologymedicine.diseasePharmacological treatmentchemistry.chemical_compoundchemistryHMG-CoA reductasemedicinebiology.proteinbusinessPravastatinmedicine.drugmedia_common
researchProduct

CLA-Enriched Diet Containing t10,c12-CLA Alters Bile Acid Homeostasis and Increases the Risk of Cholelithiasis in Mice

2011

International audience; Mice fed a mixture of CLA containing t10,c12-CLA lose fat mass and develop hyperinsulinemia and hepatic steatosis due to an accumulation of TG and cholesterol. Because cholesterol is the precursor in bile acid (BA) synthesis, we investigated whether t10,c12-CLA alters BA metabolism. In Expt. 1, female C57Bl/6J mice were fed a standard diet for 28 d supplemented with a CLA mixture (1 g/100 g) or not (controls). In Expt. 2, the feeding period was reduced to 4, 6, and 10 d. In Expt. 3, mice were fed a diet supplemented with linoleic acid, c9,t11-CLA, or t10,c12-CLA (0.4 g/100 g) for 28 d. In Expt. 1, the BA pool size was greater in CLA-fed mice than in controls and the …

Enterohepatic circulationmedicine.medical_specialtymedicine.drug_classLinoleic acid[SDV]Life Sciences [q-bio]Blotting WesternMedicine (miscellaneous)030209 endocrinology & metabolismCholesterol 7 alpha-hydroxylasePolymerase Chain ReactionBile Acids and SaltsMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRisk FactorsCholelithiasisInternal medicineHyperinsulinémiemedicineHyperinsulinemiaAnimalsHomeostasisEnterohepatic circulation030304 developmental biology0303 health sciencesNutrition and DieteticsBile acidintegumentary systemCholesterolalpha-Linolenic Acidfood and beveragesmedicine.diseaseDietary FatsBile Salt Export PumpMice Inbred C57BLCholesterol 7-alpha hydroxylaseCholesterolEndocrinologyMetabolismLiverchemistryNutrient physiologyFemalelipids (amino acids peptides and proteins)Steatosis[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor

2013

The Eph–ephrin system plays a critical role in tumor growth and vascular functions during carcinogenesis. We had previously identified cholanic acid as a competitive and reversible EphA2 antagonist able to disrupt EphA2-ephrinA1 interaction and to inhibit EphA2 activation in prostate cancer cells. Herein, we report the synthesis and biological evaluation of a set of cholanic acid derivatives obtained by conjugation of its carboxyl group with a panel of naturally occurring amino acids with the aim to improve EphA2 receptor inhibition. Structure-activity relationships indicate that conjugation of cholanic acid with linear amino acids of small size leads to effective EphA2 antagonists whereas …

EphA2 antagonistsStereochemistryStructure-activity relationship studiesPharmaceutical Sciencemedicine.disease_causeArticleProtein Structure SecondaryAnalytical Chemistrylcsh:QD241-441Inhibitory Concentration 50Structure-Activity Relationshipchemistry.chemical_compoundamino acid conjugateslcsh:Organic chemistryEphA2 anatgonistscholanic acid; amino acid conjugates; EphA2 antagonists; structure-activity relationshipsCell Line TumorDrug DiscoveryAromatic amino acidsmedicineHumansPhosphorylationPhysical and Theoretical ChemistryReceptorbile acids; EphA2 anatgonists; Structure-activity relationship studies; amino acid conjugatesbile acidschemistry.chemical_classificationBinding SitesReceptor EphA1Receptor EphA2structure-activity relationshipsOrganic ChemistryAntagonistCholic AcidsHydrogen BondingEPH receptor A2Amino acidMolecular Docking SimulationCholanic acidcholanic acidchemistryBiochemistryChemistry (miscellaneous)Molecular MedicineCarcinogenesisProtein Processing Post-TranslationalProtein BindingConjugateMolecules
researchProduct

Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?

2020

G-protein-coupled receptors constitute the most diverse and largest receptor family in the human genome, with approximately 800 different members identified. Given the well-known metabolic alterations in cancer development, we will focus specifically in the 19 G-protein-coupled receptors (GPCRs), which can be selectively activated by metabolites. These metabolite sensing GPCRs control crucial processes, such as cell proliferation, differentiation, migration, and survival after their activation. In the present review, we will describe the main functions of these metabolite sensing GPCRs and shed light on the benefits of their potential use as possible pharmacological targets for cancer treat…

G-protein-coupled receptorMetaboliteReviewComputational biologyBiologyReceptors G-Protein-CoupledBile Acids and Saltschemistry.chemical_compoundNeoplasmsmetabolite sensing GPCRBiomarkers TumormedicinecancerAnimalsHumansMolecular Targeted TherapyAmino AcidsReceptorlcsh:QH301-705.5G protein-coupled receptorCell growthDisease ManagementCancerGeneral MedicineLipid Metabolismmedicine.diseaseCancer treatmentlcsh:Biology (General)Gene Expression RegulationchemistryHuman genomeDisease SusceptibilityCancer developmentEnergy MetabolismSignal TransductionCells
researchProduct

Sterol Regulatory Element-binding Protein-1c Is Responsible for Cholesterol Regulation of Ileal Bile Acid-binding Protein Gene in Vivo

2002

Ileal bile acid-binding protein (I-BABP) is a cytosolic protein that binds bile acid (BA) specifically. In the ileum, it is thought to be implied in their enterohepatic circulation. Because the fecal excretion of BA represents the main physiological way of elimination for cholesterol (CS), the I-BABP gene could have a major function in CS homeostasis. Therefore, the I-BABP gene expression might be controlled by CS. I-BABP mRNA levels were significatively increased when the human enterocyte-like CaCo-2 cells were CS-deprived and repressed when CS were added to the medium. A highly conserved sterol regularory element-like sequence (SRE) and a putative GC box were found in human I-BABP gene pr…

Gene isoformReporter geneBile acidmedicine.drug_classCAAT boxPromoterCell BiologyBiologyBiochemistryMolecular biologyChloramphenicol acetyltransferaseGene expressionmedicineLiver X receptorMolecular BiologyJournal of Biological Chemistry
researchProduct

Porphyrin-bile acid conjugates: from saccharide recognition in the solution to the selective cancer cell fluorescence detection.

2008

This paper describes the preparation and use of conjugates of porphyrins and bile acids as ligands to bind to tumor expressed saccharides. Bile acid-porphyrin conjugates were tested for recognition of saccharides that are typically present on malignant tumor cells. Fluorescence microscopy, in vitro PDT cell killing, and PDT of subcutaneous 4T1 mouse tumors is reported. High selectivity for saccharide cancer markers and cancer cells was observed. This in vivo and in vitro study demonstrated high potential use for these compounds in targeted photodynamic therapy.

GlycosylationPorphyrinsmedicine.drug_classmedicine.medical_treatmentCarbohydratesPhotodynamic therapyApoptosisDNA FragmentationLigandsBiochemistrySensitivity and SpecificityCell LineBile Acids and Saltschemistry.chemical_compoundMiceStructure-Activity RelationshipIn vivoNeoplasmsmedicineFluorescence microscopeBiomarkers TumorAnimalsHumansPhysical and Theoretical ChemistryCell Line TransformedCell ProliferationMice Inbred BALB CBinding SitesBile acidDose-Response Relationship DrugMolecular StructureChemistryOrganic ChemistryCancer3T3 Cellsmedicine.diseasePorphyrinSolutionsCell killingBiochemistryMicroscopy FluorescencePhotochemotherapyCancer cellDrug Screening Assays AntitumorHeLa CellsOrganicbiomolecular chemistry
researchProduct

Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction

2014

Background & Aims Early allograft dysfunction (EAD) dramatically influences graft and patient outcome after orthotopic liver transplantation and its incidence is strongly determined by donor liver quality. Nevertheless, objective biomarkers, which can assess graft quality and anticipate organ function, are still lacking. This study aims to investigate whether there is a preoperative donor liver metabolomic biosignature associated with EAD. Methods A comprehensive metabolomic profiling of 124 donor liver biopsies collected before transplantation was performed by mass spectrometry coupled to liquid chromatography. Donor liver grafts were classified into two groups: showing EAD and immediate g…

Graft RejectionMalemedicine.medical_specialtyOrthotopic liver transplantationmedicine.drug_classBiopsyHistidine MetabolismGastroenterologyBile Acids and SaltsModel for End-Stage Liver DiseaseMetabolomicsPredictive Value of TestsRisk FactorsInternal medicineLipidomicsmedicineHumansMetabolomicsHistidinePhospholipidsHepatologyBile acidbusiness.industryMiddle AgedAllograftsTissue DonorsLiver TransplantationSphingomyelinsTransplantationLiverBiochemistryFemaleLysophospholipidsbusinessLiving donor liver transplantationBiomarkersJournal of Hepatology
researchProduct

Specific tyrosine phosphorylation in response to bile in Fasciola hepatica and Echinostoma friedi

2003

Protein tyrosine phosphorylation (PY) is a well-known signalling mechanism which is also involved in host-parasite interactions. Despite its transcendence, PY has been poorly studied in parasitic helminths. The aim of this study is to examine the effect of bile salts on the PY pattern in parasitic trematodes. Two distinct adult models were analysed: Echinostoma friedi, of intestinal habitat, and Fasciola hepatica, naturally inhabitant of host biliary channels. Our results show that bile salts induce specific and distinct protein PY in both trematode species, indicating that this signalling process seems to be also involved in host-trematode relationships.

ImmunologyBile Acids and Saltschemistry.chemical_compoundCricetinaeEchinostomaparasitic diseasesAnimalsFasciola hepaticaParasite hostingPhosphorylationTyrosinebiologyHost (biology)Tyrosine phosphorylationGeneral MedicineFasciola hepaticabiology.organism_classificationInfectious DiseaseschemistryBiochemistryTyrosinePhosphorylationCattleParasitologyTrematodaEchinostomaExperimental Parasitology
researchProduct

Genome-Wide Association Analysis in Primary Sclerosing Cholangitis

2010

Background & Aims We aimed to characterize the genetic susceptibility to primary sclerosing cholangitis (PSC) by means of a genome-wide association analysis of single nucleotide polymorphism (SNP) markers. Methods A total of 443,816 SNPs on the Affymetrix SNP Array 5.0 (Affymetrix, Santa Clara, CA) were genotyped in 285 Norwegian PSC patients and 298 healthy controls. Associations detected in this discovery panel were re-examined in independent case-control panels from Scandinavia (137 PSC cases and 368 controls), Belgium/The Netherlands (229 PSC cases and 735 controls), and Germany (400 cases and 1832 controls). Results The strongest associations were detected near HLA-B at chromosome 6p21…

LOCIMacrophage Stimulating 1 (Hepatocyte Growth Factor-Like)Genome-wide association studySUSCEPTIBILITYGene FrequencyHLA AntigensRisk FactorsHEPATOCELLULAR-CARCINOMAOdds RatioBileBiliary TractINCREASED RISKOligonucleotide Array Sequence AnalysisGastroenterologyMULTIPLE-SCLEROSISCROHNS-DISEASEEuropePhenotypeULCERATIVE-COLITISInflammation MediatorsSNP arrayCholangitis SclerosingSingle-nucleotide polymorphismLocus (genetics)Human leukocyte antigenBiologyPolymorphism Single NucleotideRisk AssessmentCell LinePrimary sclerosing cholangitisGlypicansGenetic predispositionmedicineHumansGenetic Predisposition to DiseaseGene SilencingACID RECEPTOR TGR5Genetic associationInflammationChi-Square DistributionHepatologyGene Expression ProfilingGlypican 6medicine.diseaseGENEG-Protein-Coupled Bile Acid Receptor 1Case-Control StudiesImmunologyColitis UlcerativeGenome-Wide Association StudyINFLAMMATORY-BOWEL-DISEASEGastroenterology
researchProduct

Liposome Formation from Bile Salt–Lipid Micelles in the Digestion and Drug Delivery Model FaSSIFmod Estimated by Combined Time-Resolved Neutron and D…

2011

The flow of bile secretion into the human digestive system was simulated by the dilution of a bile salt-lipid micellar solution. The structural development upon the dilution of the fed state bile model FeSSIF(mod6.5) to the fasted state bile model FaSSIF(mod) was investigated by small-angle neutron scattering (SANS) and dynamic light scattering (DLS) in crossed beam experiments to observe small and large structures in a size range of 1 nm to 50 μm in parallel. Because of the physiologically low lipid and surfactant concentrations of 2.625 mM egg-phosphatidylcholine and 10.5 mM taurocholate the sensitivity of the neutron-structural investigations was improved by partial solvent deuteration w…

LightAnalytical chemistryPharmaceutical ScienceMicelleBile Acids and SaltsGastric AcidSurface-Active Agentschemistry.chemical_compoundDrug Delivery SystemsPulmonary surfactantDynamic light scatteringDrug DiscoveryHumansScattering RadiationParticle SizeSodium dodecyl sulfateMicellesLiposomeChromatographyVesicleModels TheoreticalDilutionchemistryLiposomesMolecular MedicineParticle sizeMolecular Pharmaceutics
researchProduct